Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss

Journal of the American Academy of Dermatology

Volumn 48, Issue 2 SUPPL., 2003, Pages 253-262

  Olsen, Elise A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOXIDIL; PLACEBO;

CLINICAL EXAMINATION; CLINICAL TRIAL; DENSITY; GROWTH RATE; HAIR GROWTH; HAIR LOSS; HISTOPATHOLOGY; HUMAN; PHENOTYPE; PHOTOGRAPHY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; THICKNESS; TREATMENT OUTCOME;

EID: 0037326019     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.81     Document Type: Review

References (32)

1. Olsen EA, Weiner MS, DeLong E, Pinnell SR. Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 1985;13:185-92.
2. Olsen EA, DeLong E, Weiner MS. Effect of time on male pattern baldness [reply]. J Am Acad Dermatol 1987;76:393-4.
3. Olsen EA. Female pattern hair loss. J Am Acad Dermatol 2001; 45(Suppl):S70-80.
4. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975;68:1359-65.
5. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci 1951;53:708-23.
6. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977;97:247-54.
7. Olsen EA. The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 1999;40:106-9.
8. Olsen EA, DeLong E. Transdermal viprostol in the treatment of male pattern baldness. J Am Acad Dermatol 1990;23:470-2.
9. Rushton DH, Mortimer C, James KC. The unit area trichogram in the assessment of androgen dependent alopecia. Br J Dermatol 1983;109:429-37.
10. Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001;144:297-304.
11. Elliott K, Stephenson TJ, Messenger AG. Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. J Invest Dermatol 1999;113:873-7.
12. Olsen EA, Buller TA, DeLong E, Weiner MS. Natural history of androgenetic alopecia. Clin Exp Dermatol 1990;15:34-6.
13. Rushton DH, Ramsay ID, Norris MJ, Gilkes JJH. Natural progression of male pattern baldness in young men. Clin Exp Dermatol 1991;16:188-92.
14. The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2002;12:38-49.
15. Guarrera M, Cuilla MP. A quantative evaluation of hair loss: the phototrichogram. J Appl Cosmetol 1986;4:61-6.
16. VanNeste DJ, de Brauwer B, de Coster W. The phototrichogram: analysis of some technical factors of variation. Skin Pharmacol 1994;7:67-72.
17. Van Neste DJ, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D, et al. Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 2000;143:804-10.
18. Hoffman R. Trichoscan: combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo. Eur J Dermatol 2001;11:362-8.
19. Van Neste DJ. Contrast enhanced phototrichogram (CE-PTG): an improved non-invasive technique for measurement of scalp hair dynamics in AGA: validation study with histology after transverse sectioning of scalp biopsies. Eur J Dermatol 2001;11: 326-31.
20. Orentreich N. Scalp hair replacement in man. In: Montagna W, Dodson RL, editors. Advances in biology of skin. Vol 9: Hair growth. Oxford: Pergamon Press; 1969.
21. Randall VA, Ebling FJG. Seasonal changes in human hair growth. Br J Dermatol 1991;124:146-51.
22. Courtois M, Loussouarn G, Hourseau C, Grollier JF. Ageing and hair cycles. Br J Dermatol 1995;132:86-93.
23. Milner Y, Sudnik J, Filippi M, Kizoulis M, Kashgarian M, Stenn K. Exogen, the shedding phase of the hair cycle growth cycle: characterization of a mouse model. J Invest Dermatol 2002;119:639-44.
24. Hornung RL, Rhodes J, West DP, Girman J. Interrater agreement of Savin density and pattern scales for male pattern hair loss. J Invest Dermatol 2000;114:887.
25. Olsen EA. Androgenetic alopecia. In: Disorders of hair growth: diagnosis and treatment. New York: McGraw-Hill; 1994. p. 257-83.
26. Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Invest Dermatol 1999;4:282-4.
27. Price VH, Menefee E. Quantitative estimation of hair growth: I: androgenetic alopecia in women, effect of minoxidil. J Invest Dermatol 1990;95:683-7.
28. Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol 1999;41:717-21.
29. Kaufman KD, Olsen EA, Whiting DA, Savin R, De Villez R, Bergfield W, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39:578-88.
30. Canfield D. Photographic documentation of hair growth in androgenetic alopecia. Dermatol Clin 1996;14:713-21.
31. Kaufman K, Binkowitz B, Savin R, Canfield D. Reproducibility of global photographic assessments of patients with male pattern baldness in a clinical trial with finasteride. J Invest Dermatol 1995;104:659.
32. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. Randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in males. J Am Acad Dermatol 2002;47: 377-85.